Pharmaceutical collaborations expand as Flagship Pioneering expands its partnership with GSK, signing agreements with ...

Moderna has announced a $140 million investment to enhance its Massachusetts manufacturing capacity, a move that supports ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

Jay Bregman, co-founder of Andel, the cost and operational complexity of covering GLP-1 medications.

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

Cancerguard, a multi-cancer early detection blood test.

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings Institution, he provides a broad overview of the possible positive and negative ...

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...

Moderna's $140 million investment in Norwood, Massachusetts, aims to complete its U.S. manufacturing loop, enhancing ...

Craig Ackerman, partner in the Alexander Group and lead of its medical device practice, discusses how AI is being used and ...

Johnson & Johnson acquires Halda Therapeutics for $3 billion to strengthen its oncology portfolio, focusing on prostate ...